Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 10/20 | 0.54 |
| ▸ | PCSK6 | P29122 | 1/20 | 0.54 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.46 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.46 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.45 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | ECE1 | P42892 | 1/20 | 0.43 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.42 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.42 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.42 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.42 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29510727 | 1.00 | FURIN (0.54) | FURINPCSK6SIRT6SIRT1SIRT5 | |
| SCHEMBL29510734 | 0.95 | FURIN (0.52) | FURINPCSK6SIRT6SIRT1SIRT5 | |
| SCHEMBL29510666 | 0.89 | GNPAT (0.52) | FURINPCSK6SIRT6SIRT1SIRT5 | |
| SCHEMBL29514694 | 0.88 | FURIN (0.49) | FURINPCSK6SIRT5 | |
| SCHEMBL14028952 | 0.87 | FURIN (0.47) | FURINPCSK6SIRT6SIRT1CTSL | |
| SCHEMBL13811923 | 0.84 | SIRT6 (0.52) | FURINPCSK6SIRT6SIRT1CTSL | |
| SCHEMBL29974325 | 0.84 | GRIN2D (0.51) | FURINPCSK6SIRT5GRIN2DGRIN3B | |
| SCHEMBL29974539 | 0.84 | GRIN2D (0.51) | FURINPCSK6SIRT5GRIN2DGRIN3B | |
| SCHEMBL13811915 | 0.83 | SIRT6 (0.62) | FURINPCSK6SIRT6SIRT1SIRT5 | |
| SCHEMBL29510852 | 0.82 | FURIN (0.42) | FURINPCSK6CTSLECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260008811-A1 | BIOACTIVE PEPTIDES AND COMPOSITIONS COMPRISING THEM | ESPIKEM S.R.L. (IT) | 2026-01-08 | — | — | US | disclosed |
| US-12428444-B2 | Bioactive peptides and compositions comprising them | ESPIKEM S.R.L. (IT) | 2025-09-30 | — | — | US | disclosed |
| EP-3980134-B1 | BIOACTIVE PEPTIDES AND COMPOSITIONS COMPRISING THEM | ESPIKEM S R L (IT) | 2023-07-26 | — | — | EP | disclosed |
| US-20220227807-A1 | BIOACTIVE PEPTIDES AND COMPOSITIONS COMPRISING THEM | ESPIKEM S.R.L. (IT) | 2022-07-21 | — | — | US | disclosed |
| EP-3980134-A1 | BIOACTIVE PEPTIDES AND COMPOSITIONS COMPRISING THEM | Espikem S.r.l. (IT) | 2022-04-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008811-A1 | BIOACTIVE PEPTIDES AND COMPOSITIONS COMPRISING THEM | COL14A1, COL2A1, COL1A1 | FURIN 1909/4885PCSK6 1404/4885SIRT6 1427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.